NovoCure Limited

IPO

Novocure | cancer therapy: Tumor Treating Fields (TTFields)

Public · Saint Helier, Jersey · Founded 2000 · $95.0M raised

Headquarters
Saint Helier
Employees
1001–5000
Founded
2000
Business Model
B2B
Total Funding
$95.0M
Last Round
$95.0M Venture RoundJan 2015
Rounds
2
Type
Public

About

Novocure is an oncology company developing Tumor Treating Fields (TTFields) therapy as a novel cancer treatment modality.

Summary

NovoCure Limited is a Biotech company based in Saint Helier, Jersey, founded in 2000. It has raised $95.0M in total across 2 rounds, most recently a $95.0M Venture Round round in Jan 2015. Investors include Pharmakon Advisors, Pfizer Ventures and Index Ventures.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

IPOOct 2015
$158.0M

Sign up to see all 4 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies